Thoracoabdominal aortic aneurysms (TAAA) are a complex disease and unique to each patient’s anatomy. A consistent approach can be a powerful tool to simplify this variability. Inner-branch technology (iBEVAR) has the potential to bring greater predictability to both decision making and treatment. Ultimately, this single comprehensive approach can help physicians gain experience and build confidence in the endovascular treatment of TAAA’s.
Learn from the Experts
Podcasts
Episodes
1. What is the percentage of your current Cases where you choose inner branches?
2. Semi and twin branches: Do you have any experience with one of these features?
3. Where do you see the need for semi branches?
4. Would semi branches compete with fenestrations in a near future?
Clinical Studies
At Artivion, we partner with vascular surgeons to develop cutting-edge technologies to treat patients with TAAA. We are committed to collecting and sharing clinical data related to our aortic-centered technologies to further the science of aortic disease treatment.
Check out some of our most recent clinical studies.
INBREED Registry
Early Outcomes of a Novel Off the Shelf Preloaded Inner Branch Endograft for the Treatment of Complex Aortic Pathologies in the ItaliaN Branched Registry of E‑nside EnDograft (INBREED)
EXTENT Study
Medium-term Outcomes of E‑xtra Design Engineering inner branch Endografts for the Treatment of Complex Aortic Aneurysms from a Multicentre Collaboration.
CELER Registry
Inner branched complex aortic repair outcomes from a national multicenter registry using the E‑xtra design platform
Elite Education
Learn more about our products through educational videos. Artivion has long been recognized as a leader in the mentorship, training and support of Health Care Providers around the world. For over 20 years Artivion has provided training and support through various educational summits, physician training events, physician mentorship and institutional wet lab support.
Contact Us
Caution: All products and indications are not available/approved in all markets. The availability of custom-made devices is subject to local regulatory guidelines. E-xtra Design MultiBranch Stent Graft System is a custom-made device for a particularly identified patient manufactured by JOTEC GmbH. All trademarks are owned by Artivion, Inc, or its subsidiaries. JOTEC GmbH is a wholly owned subsidiary of Artivion, Inc.

JOTEC GmbH, Lotzenäcker 23, 72379 Hechingen, Germany
MWENG0024.005 (2026-04)





